Veterinary Medicines

Gentamox, süstesuspensioon

Authorised
  • Gentamicin
  • Amoxicillin trihydrate
Download as PDF

Product identification

Medicine name:
Gentamox, süstesuspensioon
Active substance:
  • Gentamicin
  • Amoxicillin trihydrate
Target species:
  • Cattle
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Gentamicin
    40.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Amoxicillin trihydrate
    150.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        90
        day
      • Milk
        2
        day
    • Pig
      • Meat and offal
        90
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA97
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1376
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 14/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."